Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Basel, Switzerland : MDPI Publishing
    • الموضوع:
    • نبذة مختصرة :
      Introduction: The human intestinal tract reacts to extensive resection with spontaneous intestinal adaptation. We analyzed whether gene expression analyses or intestinal permeability (IP) testing could provide biomarkers to describe regulation mechanisms in the intestinal barrier in short bowel syndrome (SBS) patients during adaptive response or treatment with the glucagon-like peptide-2 analog teduglutide.
      Methods: Relevant regions of the GLP-2 receptor gene were sequenced. Gene expression analyses and immunohistochemistry were performed from mucosal biopsies. IP was assessed using a carbohydrate oral ingestion test.
      Results: The study includes 59 SBS patients and 19 controls. Increases in gene expression with teduglutide were received for sucrase-isomaltase, sodium/glucose cotransporter 1, and calcium/calmodulin serine protein kinase. Mannitol recovery was decreased in SBS but elevated with teduglutide (Δ 40%), showed a positive correlation with remnant small bowel and an inverse correlation with parenteral support.
      Conclusions: Biomarkers predicting clinical and functional features in human SBS are very limited. Altered specific gene expression was shown for genes involved in nutrient transport but not for genes controlling tight junctions. However, mannitol recovery proved useful in describing the absorptive capacity of the gut during adaptation and treatment with teduglutide.
    • References:
      Gastroenterology. 2003 Apr;124(4):1111-34. (PMID: 12671904)
      Gut. 2005 Sep;54(9):1224-31. (PMID: 16099790)
      Am J Surg. 2001 Jun;181(6):571-5. (PMID: 11513789)
      Compr Physiol. 2018 Jun 18;8(3):1185-1210. (PMID: 29978894)
      J Biol Chem. 1992 Apr 15;267(11):7863-70. (PMID: 1560017)
      Annu Rev Physiol. 2014;76:561-83. (PMID: 24161075)
      JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):8S-13S. (PMID: 24486858)
      Digestion. 1990;46 Suppl 2:467-71. (PMID: 2262074)
      J Pediatr Surg. 2000 May;35(5):661-4. (PMID: 10813318)
      Cells. 2020 Aug 17;9(8):. (PMID: 32824536)
      Gut. 2000 Jul;47(1):112-9. (PMID: 10861272)
      Diabetes Ther. 2010 Dec;1(2):57-92. (PMID: 22127746)
      Gastroenterology. 1995 Mar;108(3):687-96. (PMID: 7875471)
      Mol Biol Cell. 2009 Nov;20(21):4489-99. (PMID: 19726564)
      Nutr Clin Pract. 2023 Jun 9;:. (PMID: 37294295)
      Clin Transl Gastroenterol. 2016 Feb 04;7:e142. (PMID: 26844839)
      Dig Liver Dis. 2020 Mar;52(3):253-261. (PMID: 31892505)
      Diagn Pathol. 2012 Jan 23;7:9. (PMID: 22268990)
      Endocrinology. 2009 Feb;150(2):592-9. (PMID: 18845625)
      Inflamm Bowel Dis. 2013 Dec;19(13):2840-7. (PMID: 24141710)
      Indian J Nephrol. 2015 Sep-Oct;25(5):287-91. (PMID: 26628794)
      J Cell Biol. 1998 Jul 13;142(1):129-38. (PMID: 9660868)
      Am J Physiol Gastrointest Liver Physiol. 2013 Jun 1;304(11):G970-9. (PMID: 23538493)
      Gastroenterology. 2010 Jun;138(7):2447-56. (PMID: 20226187)
      JPEN J Parenter Enteral Nutr. 2020 May;44(4):697-702. (PMID: 31423614)
      BMC Gastroenterol. 2014 Nov 18;14:189. (PMID: 25407511)
      Inflamm Bowel Dis. 2016 Oct;22(10):2356-68. (PMID: 27598741)
      Gastroenterology. 2012 Dec;143(6):1473-1481.e3. (PMID: 22982184)
      Cell. 1998 Sep 18;94(6):761-71. (PMID: 9753323)
      Proc Soc Exp Biol Med. 1992 Jan;199(1):75-80. (PMID: 1728040)
      Clin Nutr. 2008 Jun;27(3):328-39. (PMID: 18440672)
      Gut. 2011 Jul;60(7):902-14. (PMID: 21317170)
      J Immunol. 1984 Oct;133(4):1710-5. (PMID: 6206131)
      Regul Pept. 2012 Oct 10;178(1-3):95-101. (PMID: 22809889)
      Am J Physiol Gastrointest Liver Physiol. 2000 Mar;278(3):G425-8. (PMID: 10712262)
      Gastroenterology. 2003 May;124(5):1210-9. (PMID: 12730862)
      Gastroenterology. 2000 Sep;119(3):744-55. (PMID: 10982769)
      J Cell Biol. 1990 Aug;111(2):567-80. (PMID: 1696264)
      MedGenMed. 2004 May 13;6(2):12. (PMID: 15266238)
      Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1175-84. (PMID: 18256135)
      Neurogastroenterol Motil. 2016 Jul;28(7):957-65. (PMID: 27339216)
      Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G887-98. (PMID: 27012770)
      Dig Dis Sci. 2019 Oct;64(10):2717-2735. (PMID: 31410752)
      Adv Clin Chem. 2014;67:73-150. (PMID: 25735860)
      Gastroenterology. 1992 Feb;102(2):497-504. (PMID: 1732121)
      Ann N Y Acad Sci. 2009 May;1165:74-81. (PMID: 19538291)
      J Clin Invest. 2000 May;105(9):1217-25. (PMID: 10791996)
      Gastroenterology. 2000 Dec;119(6):1496-505. (PMID: 11113071)
      Best Pract Res Clin Gastroenterol. 2016 Apr;30(2):173-85. (PMID: 27086884)
      Dig Dis Sci. 2020 Dec;65(12):3521-3537. (PMID: 32072437)
      Curr Opin Organ Transplant. 2016 Apr;21(2):147-52. (PMID: 26881493)
      Clin Nutr. 2020 Sep;39(9):2856-2862. (PMID: 31932048)
      Front Physiol. 2019 Jan 15;9:1962. (PMID: 30697168)
      J Biol Chem. 2001 Jun 15;276(24):21489-99. (PMID: 11262390)
      Front Nutr. 2022 Jun 23;9:866048. (PMID: 35811959)
      Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7911-6. (PMID: 8755576)
      Clin Exp Gastroenterol. 2011;4:189-96. (PMID: 22016579)
      Cells. 2023 Jan 05;12(2):. (PMID: 36672170)
      Am J Physiol. 1997 Dec;273(6):R1965-71. (PMID: 9435650)
      Endocrinology. 2001 Feb;142(2):521-7. (PMID: 11159819)
      Gut. 2006 Mar;55(3):342-7. (PMID: 16000642)
      Int J Colorectal Dis. 2012 May;27(5):565-73. (PMID: 22065112)
      Curr Protoc Pharmacol. 2008 Jun;Chapter 7:Unit 7.12. (PMID: 22294233)
      J Lab Autom. 2015 Apr;20(2):107-26. (PMID: 25586998)
      Gastroenterology. 2018 Mar;154(4):874-885. (PMID: 29174926)
      Am J Physiol. 1981 Dec;241(6):E473-80. (PMID: 7325229)
      Clin Nutr. 2019 Aug;38(4):1745-1755. (PMID: 30145039)
      JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1089-1095. (PMID: 26223941)
      Inflamm Bowel Dis. 2012 Oct;18(10):1932-9. (PMID: 22344959)
      Therap Adv Gastroenterol. 2020 Apr 20;13:1756284820905766. (PMID: 32341691)
      Clin Nutr ESPEN. 2022 Oct;51:222-230. (PMID: 36184208)
      Mol Biol Cell. 2003 Jul;14(7):2959-71. (PMID: 12857878)
      Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1569-73. (PMID: 9990065)
      Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):22-31. (PMID: 16929363)
      Genome Res. 2001 May;11(5):863-74. (PMID: 11337480)
      Nat Methods. 2010 Apr;7(4):248-9. (PMID: 20354512)
      Gastroenterology. 2021 Aug;161(2):463-475.e13. (PMID: 33865841)
      Scand J Gastroenterol. 2014 Oct;49(10):1191-200. (PMID: 25098938)
      ACS Pharmacol Transl Sci. 2019 Mar 01;2(2):134-142. (PMID: 32219218)
      United European Gastroenterol J. 2018 Mar;6(2):181-191. (PMID: 29511548)
      Clin Nutr. 2010 Apr;29(2):235-42. (PMID: 19744750)
      Theranostics. 2020 Jun 12;10(17):7561-7580. (PMID: 32685005)
      Gut. 1994 Jan;35(1 Suppl):S18-22. (PMID: 8125384)
      Semin Cell Dev Biol. 2014 Dec;36:166-76. (PMID: 25220018)
      Curr Opin Clin Nutr Metab Care. 2007 Sep;10(5):620-6. (PMID: 17693747)
      Clin Nutr. 2016 Apr;35(2):247-307. (PMID: 26944585)
      Am J Surg Pathol. 2004 Oct;28(10):1352-9. (PMID: 15371952)
      Cell. 1982 Nov;31(1):11-24. (PMID: 6186379)
      Clin Nutr. 2021 Apr;40(4):2244-2251. (PMID: 33077272)
      JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):23S-31S. (PMID: 24586019)
      Gastroenterology. 1978 Apr;74(4):683-90. (PMID: 631505)
      Acta Physiol Scand. 1991 Nov;143(3):271-7. (PMID: 1772035)
      Biochem Biophys Res Commun. 2007 Jun 15;357(4):1124-9. (PMID: 17466947)
      Am J Physiol. 1992 Jan;262(1 Pt 1):G123-30. (PMID: 1733257)
      J Cell Physiol. 2000 Mar;182(3):311-22. (PMID: 10653597)
      Am J Physiol. 1997 Jun;272(6 Pt 1):E1050-8. (PMID: 9227451)
      Amino Acids. 2005 Nov;29(3):177-205. (PMID: 16082501)
      Pharmacol Res. 2007 Sep;56(3):224-36. (PMID: 17681807)
      Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E233-E242. (PMID: 28611027)
      Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:47-53; discussion 53-6. (PMID: 9467978)
      Pediatr Res. 2002 Oct;52(4):498-503. (PMID: 12357042)
      Pflugers Arch. 2020 Sep;472(9):1207-1248. (PMID: 32829466)
      Am J Physiol. 1997 Jul;273(1 Pt 1):E77-84. (PMID: 9252482)
      Endocrinology. 2000 Nov;141(11):4194-201. (PMID: 11089553)
      Comp Biochem Physiol A Comp Physiol. 1987;86(3):565-7. (PMID: 2881698)
      Allergy. 2004 Oct;59(10):1118-23. (PMID: 15355472)
      Am J Physiol Gastrointest Liver Physiol. 2014 Feb;306(3):G218-28. (PMID: 24309183)
      Regul Pept. 2005 Jan 15;124(1-3):105-12. (PMID: 15544847)
      Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1936-41. (PMID: 19188603)
      Lancet. 1993 Jun 5;341(8858):1437-9. (PMID: 8099141)
      Neurogastroenterol Motil. 2012 Jun;24(6):503-12. (PMID: 22583600)
    • Grant Information:
      IIR-DE-002562 Shire Investigator Initiated Research Program; ID 130208 Zealand Company Denmark; 22/81547 Forschungsförderung of the Charité
    • Contributed Indexing:
      Keywords: chronic intestinal failure; glucagon-like peptide-2; intestinal permeability; short bowel syndrome; teduglutide
    • الرقم المعرف:
      7M19191IKG (teduglutide)
      0 (Glucagon-Like Peptide 2)
      0 (Biomarkers)
      3OWL53L36A (Mannitol)
      0 (Gastrointestinal Agents)
    • الموضوع:
      Date Created: 20231014 Date Completed: 20231023 Latest Revision: 20231023
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC10574292
    • الرقم المعرف:
      10.3390/nu15194220
    • الرقم المعرف:
      37836505